Thalia Therapeutics plc

THAT · AIM · Health Care · mcap £11m · 0.6p

Beta Briefing, track record and bull & bear case are not ready for Thalia Therapeutics plc yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 35 companies are already wired into a briefing: browse them.

Financials · LTM to 30 Jun 26

Source: results 30 Sep 26 ↗

Revenue: £7k
Operating profit: −£1.2m
Net income: −£1.5m
Free cash flow: −£1.5m
Net cash: £1.5m
Market cap: £11.1m
EV / EBIT: –
FCF yield: −13.2%
Price / book: 4.5×

Latest half-year · H1 26 vs H1 25 results 30 Sep 26 ↗

Revenue: £4k
Net income: −£755k
Cash from operations: −£745k

Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

Income statement Cash flow Balance sheet

Annual Half-yearly

Latest report: H1 26 (six months to 30 Jun 26), published 30 Sep 26 · read the results ↗

£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source

	LTM Jun 26	FY 25	FY 24
Revenue	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0
Operating profit	–	(1.2)	(1.2)
Share-based payments	(0.1)	0.0	0.0
Profit before tax	(1.5)	(1.2)	(1.2)
Tax	(0.0)	(0.0)	0.1
Net income (owners)	(1.5)	(1.2)	(1.1)
EPS basic	(0.2p)	(0.2p)	(0.3p)
EPS diluted	(0.2p)	(0.2p)	(0.3p)

	H1 26	vs H1 25	H2 25	H1 25
Revenue	0.0	n/m	0.0	0.0
Gross profit	0.0	n/m	0.0	0.0
Share-based payments	0.0	n/m	(0.1)	0.1
Profit before tax	(0.8)	n/m	(0.7)	(0.5)
Tax	0.0	n/m	(0.0)	(0.0)
Net income (owners)	(0.8)	n/m	(0.7)	(0.5)
EPS basic	(0.1p)	–	(0.1p)	(0.1p)
EPS diluted	(0.1p)	–	(0.1p)	(0.1p)

	LTM Jun 26	FY 25	FY 24
Cash from operations	(1.5)	(1.2)	(1.0)
Tax paid	–	0.1	0.1
Shares issued	1.2	1.8	0.6

	H1 26	vs H1 25	H2 25	H1 25
Cash from operations	(0.7)	n/m	(0.7)	(0.4)
Shares issued	1.2	−33%	0.0	1.8

	Latest Jun 26	FY 25	FY 24
Goodwill	–	0.0	0.0
Trade receivables	1.2	0.1	0.1
Cash	1.5	1.1	0.6
Total assets	2.7	1.2	0.8
Trade payables	0.2	0.0	0.0
Total liabilities	0.2	0.1	0.1
Non-controlling interests	(0.0)	0.0	0.0
Total equity	2.5	1.1	0.7

	H1 26	H2 25	H1 25	H2 24
Goodwill	–	0.0	–	0.0
Trade receivables	1.2	0.1	0.1	0.1
Cash	1.5	1.1	1.7	0.6
Total assets	2.7	1.2	1.8	0.8
Trade payables	0.2	0.0	0.0	0.0
Total liabilities	0.2	0.1	0.1	0.1
Non-controlling interests	(0.0)	0.0	0.0	0.0
Total equity	2.5	1.1	1.8	0.7

Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.

Company filings. Not investment advice.